Valuation Bayer AG

Equities

Market Closed - Xetra Other stock markets 16:35:10 13/09/2024 BST			5-day change	1st Jan Change
26.98 ^EUR	+0.71%		-6.68%	-19.77%

09-13	RTW Biotech half-year net asset value rises amid "challenging markets"	AN
09-12	German Shares Advance as ECB Delivers Widely Expected Rate Cut	MT

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Capitalization ¹	71,530	47,309	46,174	47,476	33,039	26,506	-	-
Change	-	-33.86%	-2.4%	2.82%	-30.41%	-19.77%	-	-
Enterprise Value (EV) ¹	105,598	84,884	79,140	78,749	67,302	60,389	56,946	53,481
Change	-	-19.62%	-6.77%	-0.49%	-14.54%	-10.27%	-5.7%	-6.09%
P/E ratio	17.5x	-4.51x	46.1x	11.5x	-11.2x	11.4x	8.9x	7.93x
PBR	1.51x	1.55x	1.4x	1.22x	1x	0.77x	0.69x	0.64x
PEG	-	0x	-0x	0x	0x	-0x	0.3x	0.7x
Capitalization / Revenue	1.64x	1.14x	1.05x	0.94x	0.69x	0.56x	0.56x	0.55x
EV / Revenue	2.43x	2.05x	1.8x	1.55x	1.41x	1.28x	1.19x	1.1x
EV / EBITDA	9.18x	7.41x	7.08x	5.83x	5.75x	5.78x	5.29x	4.9x
EV / EBIT	15.1x	12x	10.8x	8.51x	8.87x	9.15x	8.28x	7.61x
EV / FCF	19x	34.2x	31.9x	19x	28.4x	18.4x	13.5x	13.7x
FCF Yield	5.26%	2.93%	3.13%	5.26%	3.52%	5.45%	7.39%	7.29%
Dividend per Share ²	2.8	2	2	2.4	0.11	0.1103	0.1103	1.118
Rate of return	3.85%	4.15%	4.26%	4.97%	0.33%	0.41%	0.41%	4.14%
EPS ²	4.17	-10.68	1.02	4.22	-2.99	2.373	3.032	3.4
Distribution rate	67.1%	-18.7%	196%	56.9%	-3.68%	4.65%	3.64%	32.9%
Net sales ¹	43,545	41,400	44,081	50,739	47,637	47,012	47,675	48,402
EBITDA ¹	11,503	11,461	11,179	13,513	11,706	10,439	10,758	10,916
EBIT ¹	7,007	7,095	7,295	9,257	7,589	6,598	6,876	7,023
Net income ¹	4,091	-10,495	1,000	4,150	-2,941	2,277	3,015	3,426
Net Debt ¹	34,068	37,575	32,966	31,273	34,263	33,883	30,441	26,975
Reference price ²	72.81	48.16	47.00	48.32	33.63	26.98	26.98	26.98
Nbr of stocks (in thousands)	982,424	982,424	982,424	982,424	982,424	982,424	-	-
Announcement Date	27/02/20	25/02/21	01/03/22	28/02/23	05/03/24	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E ratio	EV / Sales	EV / EBITDA	Yield (Y)	Capi. ($)
BAYER AG	11.37x	1.28x	5.78x	+0.41%	29.39B
ELI LILLY AND COMPANY	59.56x	18.45x	44.86x	+0.56%	832B
NOVO NORDISK A/S	40.44x	14.09x	28.68x	+1.24%	605B
JOHNSON & JOHNSON	22.5x	4.58x	12.96x	+2.83%	398B
ABBVIE INC.	37.8x	7.16x	15.47x	+3.21%	343B
MERCK & CO., INC.	15.45x	4.91x	11.25x	+2.65%	294B
ROCHE HOLDING AG	15.86x	3.76x	9.85x	+3.71%	252B
ASTRAZENECA PLC	28.09x	5.05x	14.99x	+1.98%	243B
NOVARTIS AG	21.48x	4.95x	12.54x	+3.26%	234B
AMGEN INC.	51.21x	6.89x	12.07x	+2.76%	179B
Average	30.38x	7.11x	16.84x	+2.26%	340.95B
Weighted average by Cap.	36.90x	10.03x	23.41x	+2.03%